{"abstract":"The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.","action":"Notice; establishment of a public docket; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/05/06/2019-09212.html","cfr_references":[],"citation":"84 FR 19788","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on June 20, 2019, from 8 a.m. to 4:30 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-N-1620"],"dockets":[],"document_number":"2019-09212","effective_on":null,"end_page":19789,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/05/06/2019-09212.xml","html_url":"https://www.federalregister.gov/documents/2019/05/06/2019-09212/pediatric-oncology-subcommittee-of-the-oncologic-drugs-advisory-committee-notice-of-meeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-09212?publication_date=2019-05-06","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-05-06/2019-09212/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":389,"last_updated":"2026-07-26 16:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-05-06/pdf/2019-09212.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-09212.pdf?1556887524","publication_date":"2019-05-06","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/05/06/2019-09212.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-N-1620","supporting_documents_count":0,"docket_id":"FDA-2019-N-1620","regulation_id_number":null,"title":"Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments","checked_regulationsdotgov_at":"2019-06-21T03:00:08Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":19788,"subtype":null,"title":"Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments","toc_doc":"Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":84}